Seagen Inc.
BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS
Last updated:
Abstract:
The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2021
Issue date:
27 Jan 2022